Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1398 of 5804
-
Could a sleep drug improve social skills in autism?
Symptom relief OngoingProof of concept, multicenter, randomized, double-blind, placebo-controlled, parallel-group, study to investigate the effect, safety, tolerability and pharmacokinetics of pitolisant in male children and adolescents with Autism Spectrum Disorders.
Phase: PHASE2 • Sponsor: Bioprojet • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Zapping the brain to fight Alzheimer's memory loss
Symptom relief Recruiting nowThe investigators will evaluate the theory that Alzheimer's disease-related memory impairment derives from the inefficient orchestration of rhythmic activity at the level of large-scale cortical networks. The results as expected to elucidate AD-related pathophysiology and set gro…
Phase: NA • Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Jun 26, 2026 18:53 UTC
-
New injection may replace radiation for eye cancer, offering fewer side effects
Disease control Recruiting nowThis project proposes to establish a prospective, multicenter, randomized, controlled clinical study to compare the safety and efficacy of Intralesional Rituximab Injection versus Involved Site Radiation Therapy for the treatment of primary ocular adnexal MALT lymphoma. The aim i…
Phase: NA • Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New heart failure pill shows promise in early trial
Disease control CompletedThis study will evaluate the efficacy, safety, tolerability and pharmacokinetics of JTT-861 administered once daily for 12 weeks in subjects with heart failure with reduced ejection fraction (HFrEF) who are on a stable, guideline-directed medical therapy for heart failure.
Phase: PHASE2 • Sponsor: Akros Pharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for rare disease: can NS-229 help patients reduce steroids?
Disease control OngoingThis study will enroll male and female subjects who are 18 years of age or older with Eosinophilic Granulomatosis With Polyangiitis.
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Breathing easier, lowering pressure: HEPA filters tested in NYC housing
Disease control Recruiting nowFine particulate matter \<2.5 µm (PM2.5) air pollution is the fifth leading risk factor for global mortality, with the largest portion of deaths due to cardiovascular disease (CVD). While several mechanisms are responsible, PM2.5-induced elevations in blood pressure (BP) may be r…
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New cocktail aims to shrink Hard-to-Treat colon tumors
Disease control OngoingThe main purpose of this clinical trial is to learn about the good and the bad effects of all trans retinoic acid (ATRA), atezolizumab and bevacizumab as a possible treatment for advanced colorectal patients. Participants will be treated with the following combination of these d…
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Drug combo shows promise for rare skin disease in kids
Disease control CompletedIn this study, we describe our experience with secukinumab (IL-17A inhibitor) and dupilumab (IL-4/IL-13 inhibitor) treatment of a group of pediatric patients with severe Neterton syndrome.
Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology • Aim: Disease control
Last updated Jun 26, 2026 13:45 UTC
-
Can a simple infusion shield kidneys during heart surgery?
Disease control CompletedThe aim of this clinical trial is to evaluate the efficacy and safety of two intravenous administrations of ilofotase alfa in patients at risk for renal damage following open heart surgery.
Phase: PHASE2 • Sponsor: AM-Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could a cancer drug fix a bleeding disorder and prevent leukemia?
Disease control Recruiting nowBackground: Runt-related transcription factor 1 (RUNX1) gene regulates the formation of blood cells. People with mutations of this gene may bleed or bruise easily; they are also at higher risk of getting cancers of the blood, bone marrow, and lymph nodes. Objective: The purpos…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New scan could help Crohn's patients avoid unnecessary surgery
Diagnosis Recruiting nowIn this study twenty-five (25) subjects with Crohn's disease scheduled for possible surgical intervention will be recruited for this study and a PET/MR scan using the collagen-binding radiotracer will be performed. The study aims to establish the performance figures of PET/MR usi…
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Blood test may outsmart ovarian cancer relapse
Knowledge-focused Recruiting nowOvarian cancer (OC) is the third most common gynaecologic cancer worldwide and has the highest mortality rate among gynaecologic cancers. Despite the advances in cytoreductive surgery and frontline chemotherapy, recurrence is a common event in the advanced disease setting, with m…
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New surgery aims to drain chronic swelling in cancer survivors
Symptom relief Recruiting nowThe goal of this randomized controlled trial is to compare the effectiveness and cost-effectiveness of lymphaticovenous anastomosis (LVA) with sham surgery for patients suffering from unilateral cancer-related lymphedema in either the upper or lower extremity. It aims to answer w…
Phase: NA • Sponsor: Maastricht University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Grow your own heart valve: first human trial launches
Disease control Recruiting nowAim of this study is to investigate the clinical safety of a novel pediatric heart valve.
Phase: NA • Sponsor: Charite University, Berlin, Germany • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Donated skin and your own cells may fix massive shoulder tears
Disease control Recruiting nowThe use of biologic acellular matrices for the surgical augmentation of rotator cuff lesions has greatly expanded inrecent years. The study team patented a method for removing cells from human dermis (Acellular Dermal Matrix), maintaining unaltered biological and structural integ…
Phase: NA • Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New combo therapy aims to deepen remissions in CLL
Disease control OngoingStudy is a phase I study to determine the maximum tolerated dose of adding Loncastuximab Tesirine to Aclabrutinib in the treatment of chronic lymphocytic leukemia.
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could cannabis compounds soothe dementia agitation? new trial investigates
Symptom relief OngoingThis is a multicenter randomized double-blind placebo-controlled Phase 2 study of an oral combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) compared to placebo over 12 weeks. This study is designed to test the hypothesis that treatment with an oral combination of TH…
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
One drug at a time: could a simpler blood thinner strategy cut bleeding risk after stents?
Disease control Recruiting nowPatients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation require treatment with different antithrombotic drugs. Oral anticoagulants are prescribed to reduce the risk of stroke associated with atrial fibrillation. Antiplatelet substan…
Phase: PHASE4 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Air cleaners tested as heart failure treatment after hospital stay
Disease control Recruiting nowACHIEVE-P4: PATHFINDER is a randomized, blinded clinical trial of portable air cleaners (PAC) provided at the time of hospital discharge to Heart Failure (HF) patients. It will be carried out at Henry Ford Hospitals. This project is part of the ACHIEVE GREATER (Addressing Cardiom…
Phase: NA • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Laos study aims to wipe out stomach cancer by targeting common gut bug
Disease control CompletedThis study aims to determine the regional prevalence of Helicobacter pylori infection, bacterial strain differences, and the prevalence of gastric cancer in two provinces of Laos, a multi-ethnic country where these factors may vary by region and ethnicity. The study also evaluate…
Sponsor: Zero Helicobacter IGAN Network • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC